Trial · NCT01877382
Participant flow90
How many started, completed or left each group, period by period.
1 to 20 of 90
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Dose Escalation | STARTED | Cohort 1: 15 mg/Day Milademetan | 3 | |
| Dose Escalation | STARTED | Cohort 2: 30 mg/Day Milademetan | 1 | |
| Dose Escalation | STARTED | Cohort 3: 60 mg/Day Milademetan | 1 | |
| Dose Escalation | STARTED | Cohort 4: 120 mg/Day Milademetan | 13 | |
| Dose Escalation | STARTED | Cohort 5: 240 mg/Day Milademetan | 2 | |
| Dose Escalation | STARTED | Cohort 6: 160 mg/Day Milademetan | 5 | |
| Dose Escalation | STARTED | Cohort 7b: 90 mg/Day Milademetan | 9 | |
| Dose Escalation | STARTED | Cohort 8c: 90 mg/Day Milademetan | 15 | |
| Dose Escalation | STARTED | Cohort 9d: 120 mg/Day Milademetan | 6 | |
| Dose Escalation | STARTED | Cohort 10e: 120 mg/Day Milademetan | 3 | |
| Dose Escalation | STARTED | Cohort 11e: 200 mg/Day Milademetan | 3 | |
| Dose Escalation | STARTED | Cohort 12d: 200 mg/Day Milademetan | 3 | |
| Dose Escalation | STARTED | Cohort 13e: 260 mg/Day Milademetan | 20 | |
| Dose Escalation | STARTED | Cohort 14e: 340 mg/Day Milademetan | 3 | |
| Dose Escalation | STARTED | Expansion Cohort: 120 mg/Day Milademetan | 0 | |
| Dose Escalation | COMPLETED | Cohort 1: 15 mg/Day Milademetan | 0 | |
| Dose Escalation | COMPLETED | Cohort 2: 30 mg/Day Milademetan | 0 | |
| Dose Escalation | COMPLETED | Cohort 3: 60 mg/Day Milademetan | 0 | |
| Dose Escalation | COMPLETED | Cohort 4: 120 mg/Day Milademetan | 0 | |
| Dose Escalation | COMPLETED | Cohort 5: 240 mg/Day Milademetan | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01877382/flow